Cory J. Fox

Associate

Houston
T 713.646.1358  |  F 713.751.1717

Cory Fox focuses his practice on assisting clients in the healthcare industry, with an emphasis on issues related to privacy and data protection pursuant to the Health Insurance Portability and Accountability Act (HIPAA) and related state law. As a former research chemist, Cory leverages his prior experience working with academic medical centers, hospitals, pharmaceutical companies, and other healthcare organizations to efficiently assess a client's internal operations and provide the targeted advice and services necessary to address the wide variety of complex legal issues healthcare organizations face.

Cory is a regular contributor to the firm's Data Privacy Monitor and Health Law Update blogs.

Select Experience

  • Represented three large academic medical centers in data breach matters involving the theft of a laptop through all phases of breach response including crisis management, incident investigation, notification of affected individuals, and reporting to the U.S. Department of Health & Human Services (HHS) Office for Civil Rights (OCR) and state regulators. Assisted with subsequent OCR investigations by responding to requests for information regarding the breach incidents as well as each entity's overall HIPAA compliance. The investigations closed with no disciplinary action taken.
  • Advised large hospital system during OCR investigation regarding the hospital's provision of auxiliary aids and services to the hearing impaired under Section 504 of the Rehabilitation Act and the Americans with Disabilities Act. Investigation closed with no disciplinary action taken.
  • Advised multiple compounding pharmacies and an industry trade organization regarding FDA regulatory issues under the Drug Quality and Security Act, including facility registration, cGMP compliance, and the submission of comments and information pursuant to FDA regulatory proposals and guidance. 
More »

Experience

  • Represented three large academic medical centers in data breach matters involving the theft of a laptop through all phases of breach response including crisis management, incident investigation, notification of affected individuals, and reporting to the U.S. Department of Health & Human Services (HHS) Office for Civil Rights (OCR) and state regulators. Assisted with subsequent OCR investigations by responding to requests for information regarding the breach incidents as well as each entity's overall HIPAA compliance. The investigations closed with no disciplinary action taken.
  • Assisted two state chartered credit unions with data breach matters involving malware attacks by coordinating internal investigations regarding the incidents, preparing notification letters and regulatory filings in accordance with applicable state and federal laws, and providing legal support following breach notification.
  • Advised large hospital system during OCR investigation regarding the hospital's provision of auxiliary aids and services to the hearing impaired under Section 504 of the Rehabilitation Act and the Americans with Disabilities Act. Investigation closed with no disciplinary action taken.
  • Advised pain management clinic regarding drug diversion matter, including reporting of the incident to the Drug Enforcement Administration (DEA) and implementation of controlled substance recordkeeping policies and procedures. Assisted with subsequent DEA investigation and audit by responding to the DEA's requests for information regarding the diversion incident and the clinic's controlled substance records. No disciplinary action has been taken against the clinic.
  • Assisted two home health agencies with the development and implementation of comprehensive compliance programs addressing fraud and abuse prevention under the Stark Law and the Anti-Kickback statute, health information privacy under HIPAA and Texas law, and operational issues associated with regulations promulgated by the Texas Department of Aging and Disability Services.
  • Advises hospitals, academic medical centers, pharmacies, physicians, and business associates regarding development, implementation, and review of health information privacy policies and procedures pursuant to HIPAA and applicable state law. Assists these entities in periodically revising privacy policies and procedures in response to statutory and regulatory amendments and addresses operational questions related to privacy and safeguarding of patient information.
  • Advised multiple compounding pharmacies and an industry trade organization regarding FDA regulatory issues under the Drug Quality and Security Act, including facility registration, cGMP compliance, and the submission of comments and information pursuant to FDA regulatory proposals and guidance.

Recognitions

  • Certified Information and Privacy Professional (CIPP/US)

Memberships

  • American Health Lawyers Association
  • International Association of Privacy Professionals
  • Food and Drug Law Institute
  • American Bar Association
  • State Bar of Texas
  • Houston Bar Association

Services

Industries

Prior Positions

  • U.S. Department of Health and Human Services Office of Counsel to the Inspector General: Summer Law Clerk (Summer 2011)
  • University of Texas Medical Branch: Law Clerk (2010 to 2012) 
  • MD Anderson Cancer Center Department of Pulmonary Medicine: Research Assistant (2009 to 2010)
  • BioAutomation: Research and Development Chemist (2007 to 2009)

Admissions

  • Texas, 2012

Education

  • J.D., University of Houston Law Center, 2012, National Order of Scribes; Chief Articles Editor, Houston Journal of Health Law & Policy; Moot Court
  • B.S., Biology and Chemistry, Texas Tech University, 2007, Beta Beta Beta Biological Honors Society

Blog

In The Blogs

Previous Next
Health Law Update
Five Things to Know About the Medicare SGR Fix
April 27, 2015
H.R. 2, the Medicare Access and CHIP Reauthorization Act (MACRA), was signed into law by President Obama on April 16, 2015. A broad bipartisan compromise measure, MACRA repeals the much-maligned sustainable growth rate (SGR) formula used...
Read More ->
Health Law Update
OIG Provides Additional Compliance Guidance for Healthcare Governing Boards
April 24, 2015
On April 20, 2015, the HHS Office of Inspector General (HHS OIG), in collaboration with the American Health Lawyers Association (AHLA), the Association of Healthcare Internal Auditors (AHIA), and the Health Care Compliance Association...
Read More ->
Health Law Update
Latest Spike in Prescription Drug Spending Prompts OIG Investigation
April 22, 2015
A new report released by the IMS Institute for Healthcare Informatics shows that U.S. spending on pharmaceuticals increased in 2014 by 13.1 percent, reaching $373.9 billion. This is the highest increase since 2001 when drug spending growth...
Read More ->
Health Law Update
Following FDA’s First Biosimilar License, CMS Issues Guidance on Reimbursement for Biosimilars
April 22, 2015
On March 6, 2015, FDA released a statement announcing its issuance of the first biosimilar license to Zarxio. In the same month, CMS issued a number of guidance documents addressing reimbursement for biosimilars under the Medicare Part B...
Read More ->
Data Privacy Monitor
Social Media’s Not For You—It’s About You: Risks for Organizations in a New Age of Sharing
April 20, 2015
Social media and social networking, including websites and applications that allow users to create and share content, have become ubiquitous. Joining the social networking revolution may be very easy for individuals, but establishing best...
Read More ->